Historical record - last NADAC effective date: 4/17/2024
Product Information
SUMATRIPTAN SUCC 50 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.3104 per EA under NDC 63304009819. Its NADAC has been published 547 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2009.
The Low Outlier badge above means this manufacturer's average price in the Sumatriptan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304009819
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA076554FDA Approved
8/10/2009
On Market Since
8/13/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 50 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has declined 62.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3104 per EA |
|---|---|
| All-time high | $1.0034 (Mar 11, 2015) |
| All-time low | $0.3104 (Apr 17, 2024) |
| Median price | $0.5705 |
| Average price | $0.6281 |
| Largest weekly change | -25.5% (Apr 17, 2024) |
| Weeks tracked | 547 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-30.1%
5Y
-41.3%
All
-62.9%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 50 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.3104 per EA (NDC 63304009819), effective May 15, 2024.
How has the price of SUMATRIPTAN SUCC 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has declined 62.9%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 50 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has ranged from a low of $0.3104 (Apr 17, 2024) to a high of $1.0034 (Mar 11, 2015), with a median of $0.5705 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 50 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN SUCC 50 MG TABLET, is $0.2994 per EA — about 4% below SUMATRIPTAN SUCC 50 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 50 MG TABLET?
SUMATRIPTAN SUCC 50 MG TABLET (NDC 63304009819) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.